The GMDN Agency is responsible for the Global Medical Device Nomenclature (GMDN) used to identify medical devices.
The GMDN Agency CEO, Deniz Bruce, and Senior Clinical Lead, Dr Barry Daniels, attended the IMDRF (International Medical Device Regulators Forum) Meeting
MHRA and ANVISA representatives have joined the Authorities Strategic Advisory Group (ASAG) committee, which represents medical device regulators that use the GMDN.
The GMDN Agency delivered three virtual strategy workshops this month (March 2023) as part of our Corporate Strategy 2022 – 2026 implementation.
The GMDN has been listening to the views of nomenclature users to help shape the future of medical device identification.